MCM
EBS icon

McKinley Capital Management’s Emergent Biosolutions EBS Stock Holding History

McKinley Capital Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-84,640
Closed -$4.09M – 184
2019
Q2 		$4.09M Buy
+84,640
New +$4.06M 0.26% 88

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

McKinley Capital Management's EBS Position: Q3 2019 in Review

McKinley Capital Management sold out of Emergent Biosolutions (EBS) in Q3 2019, closing a stake of 84,640 shares — an estimated $4.09M sold.

McKinley Capital Management first reported a position in EBS in Q2 2019 and held it in 1 quarter. The position peaked at $4.09M in Q2 2019. 244 funds tracked by Wall St. Rank hold EBS as of Q3 2019.

  • McKinley Capital Management reported no remaining Emergent Biosolutions position as of Q3 2019 after selling out during the quarter.
  • McKinley Capital Management sold 84,640 Emergent Biosolutions shares in Q3 2019, an estimated $4.09M.
  • McKinley Capital Management first reported a position in Emergent Biosolutions in Q2 2019 and held it in 1 quarter.
  • McKinley Capital Management's Emergent Biosolutions position peaked at $4.09M in Q2 2019.
  • 244 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2019.

Based on McKinley Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.